denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: AbbVie, Bristol Myers Squibb, GSK, and Karyopharm Therapeutics
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Therapies
Hematology Disease Topics & Pathways:
Therapies
Friday, December 8, 2023: 11:00 AM-2:00 PM
Marriott Grand Ballroom 8-9
(Marriott Marquis San Diego Marina)
Chair:
Prithviraj Bose, MD, The University of Texas MD Anderson Cancer Center
Disclosures:
Bose: GSK, Novartis, Karyopharm, AbbVie, Pharma Essentia, Jubilant, Morphic: Honoraria; Kartos, Telios, Disc, Janssen, Geron: Research Funding; Incyte, BMS, CTI, Morphosys, Blueprint, Cogent, Sumitomo, Ionis: Honoraria, Research Funding.
Speakers:
Stephen T. Oh, MD, PhD, Washington University School of Medicine
and
Nikolai A. Podoltsev, MD, PhD, Yale School of Medicine
Disclosures:
Oh: CTI BioPharma, Bristol Myers Squibb, Disc Medicine, Blueprint Medicines, PharmaEssentia, Constellation/MorphoSys, Geron, AbbVie, Sierra Oncology/GSK, Cogent, Incyte, Morphic, Protagonist: Consultancy. Podoltsev: AbbVie Inc.; Blueprint Medicines (former); Constellation Pharmaceuticals (former); CTI BioPharma Corp. (former); Incyte Corporation (former); Novartis (former); PharmaEssentia (former): Consultancy; AI Therapeutics; Arog Pharmaceuticals; Astellas Pharma, Inc.; Astex Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Celgene Corporation; CTI BioPharma Corp.; Daiichi Sankyo, Inc.; Genentech, Inc.; Jazz Pharmaceuticals, Inc.; Kartos Therapeuti: Research Funding; Cogent Biosciences: Other: IDMC Member.
On Demand program will be available here January 8, 2024.
This 90-minute symposium will present a comprehensive review of the recent updates related to current and emerging therapies in MF. Featuring a lively and engaging format resembling a talk show, 3 expert faculty in MF will discuss the evolving MF treatment paradigm. Discussion will review the current treatment landscape, emerging therapies, and practical management strategies to optimize patient outcomes.
See more of: Friday Satellite Symposia